<DOC>
	<DOCNO>NCT02621450</DOCNO>
	<brief_summary>End stage renal disease ( ESRD ) relate increased cardiovascular mortality morbidity . Hypertension ( HT ) important risk factor cardiovascular disorder among hemodialysis ( HD ) patient . The aim study go investigate effectivity low-sodium dialysate systolic diastolic blood pressure ( BP ) level detect ABPM interdialytic weight gain ( IDWG ) patient undergo sustained hemodialysis treatment . Methods : The study include 46 patient creatinine clearance level less 10 ml/min/1.73 m2 chronic HD treatment least one year . After enrollment stage , patient allocate low-sodium dialysate standard-sodium dialysate six month via computer-generated randomization .</brief_summary>
	<brief_title>Low Sodium Dialysate Ambulatory Blood Pressure Measurement Parameters</brief_title>
	<detailed_description>Patient Selection The present study single-center , randomize control double blind trial . The patient go enroll study creatinine clearance le 10 ml/min/1.73 m2 intermittent HD treatment least one year . The exclusion criterion present study mask white coat hypertension , heart failure , cardiomyopathy , acute coronary syndrome , chronic ischemic heart disease , acute chronic liver disease , endocrine pulmonary disease , valvular heart disease , malignancy , active urinary tract infection , hemoglobin level 8 g/dL , hypotension tendency . Sixty-four patient go enroll eligibility initial assessment . Clinic laboratory profile patient include cause renal disease , history HT antihypertensive treatment go record systematic review patient file . After enrollment stage , patient go allocate low-sodium dialysate standard sodium dialysate 6 month via computer-generated randomization . They go dialyze three time week synthetic polysulfone ( Hollow-fiber , Low Flux , KUF &lt; 20 , 1.6 m2 ) membrane , session last 4 hour bicarbonate dialysate ( 33mmol/L concentration ) 300-350 ml/min blood-flow . . Study protocol All patient go assess 6 month study . Before initiate study , patient dialyze 140 mEq/L sodium concentration . In low-sodium dialysate group , dialysate sodium concentration go reduce 140 137mEq/L . To eliminate acute effect hemodialysis parameter measure , baseline end-of-study measurement go perform non-dialysis day , 24 hour mid-week session . Ambulatory blood pressure measurement Ambulatory BP measurement 24-hour go perform use Space Labs 90207 oscillometric method ( Redmond , Washington , USA ) . The BP measurement go perform automatically non-fistula arm . The confirmation device go check standard auscultator method order ensure change BP value two method exceed +5 mm Hg . The device go set achieve BP evaluation 30-minute interval night ( 11:00 PM 07:00 AM ) 20-minute interval day ( 07:00 AM 11:00 PM ) . ''Nocturnal dipping '' go define decrease great 10 % ( compare daytime value ) systolic diastolic blood pressure night . ''Non-nocturnal dipping '' go define decrease le 10 % ( compare daytime value ) blood pressure parameter level night decrease systolic diastolic blood pressure night</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>The patient creatinine clearance le 10 ml/min/1.73 m2 intermittent HD treatment least one year include study . Exclusion Criteria follow : Masking white coat hypertension , heart failure , cardiomyopathy , acute coronary syndrome , chronic ischemic heart disease , acute chronic liver disease , endocrine pulmonary disease , valvular heart disease , malignancy , active urinary tract infection , hemoglobin level 8 g/dL , hypotension tendency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>chronic renal failure</keyword>
	<keyword>hypertension</keyword>
	<keyword>ampulatory blood pressure</keyword>
</DOC>